• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Regions

mobile-digital-phone-app
Sarmaycar, Shorooq back Pakistan fintech player OneLoad

OneLoad, a Pakistan-based digital financial services platform established by local IT player Systems Limited and the International Finance Corporation (IFC), has raised USD 11m in funding.

  • South Asia
  • 04 August 2022
gull-new-zealand
Allegro buys New Zealand fuel retail business

Australia’s Allegro Funds has agreed to acquire 100% of petrol station chain Gull New Zealand, the largest independent operator of its kind locally, for NZD 552m (USD 327m).

  • Australasia
  • 04 August 2022
avcj-220803cvr-72
Weekly digest - August 03 2022

  • Region
  • 03 August 2022
biotech-lab-drug-research-development
Portfolio: CBC Group and Ensem Therapeutics

CBC Group plans to allocate USD 300m from its latest flagship fund to a biotech incubation platform. Artificial intelligence-enabled drug discovery player Ensem Therapeutics is an example of what it wants to achieve.

  • Greater China
  • 03 August 2022
China biotech player Sironax raises $200m Series B

Gaorong Capital and Yunfeng Capital have led a USD 200m Series B round for China’s Sironax, a drug developer targeting age-related degenerative diseases.

  • Greater China
  • 03 August 2022
Qiming, Quan lead $120m Series B for China's OriCell

Qiming Venture Partners and Quan Capital have led a USD 120m Series B round for OriCell Therapeutics, a China-based drug developer that is working on CAR-T cell therapies that target cancer.

  • Greater China
  • 03 August 2022
eruvaka
Omnivore exits India agtech player Eruvaka

Indian agriculture technology specialist Omnivore Partners claims to have achieved the country’s largest exit in the sector to date with the sale of aquaculture start-up Eruvaka to Dutch strategic Nutreco.

  • South Asia
  • 03 August 2022
singapore-harbor-cityscape-night-2
Singapore's Singtel pumps $100m into VC arm

Singapore telecom giant SingTel has committed USD 100m to its VC arm Innov8. The investment unit, which operates on an evergreen fund model, has received USD 350m to date.

  • Southeast Asia
  • 03 August 2022
omar-mahmoud-creador
Deal focus: Creador goes early in digital banking

Only six digital banks are licensed to operate in the Philippines. Enthused by the prospect of helping build one of these select few from the ground up, Creador moved fast to back UnoAsia

  • Southeast Asia
  • 03 August 2022
boston-micro-fabrication-bmf-part
Deal focus: China start-up mines 3D printing’s micro potential

Supported by a string of Chinese investors, Boston Micro Fabrication has carved a niche serving global manufacturers that want 3D printing solutions for very small components

  • Greater China
  • 02 August 2022
philippines-map
Creador backs Philippines digital bank

Creador has made a rare early-stage investment, leading a pre-Series A round of USD 11m for UnoAsia, operator of Uno Digital Bank, one of only six licensed digital banks in the Philippines.

  • Southeast Asia
  • 02 August 2022
imab-biotech-drug-healthcare
China's Ribo Life Science raises $40m as part of Series E

Chinese drug developer Suzhou Ribo Life Science has raised USD 40m in the first tranche of a Series E from existing investors Panlin Capital and Trinity Innovation Fund. Several undisclosed new investors also took part.

  • Greater China
  • 02 August 2022
toomics-2
Affirma supports Korea's NPX in Terapin Studios deal

Affirma Capital has confirmed a USD 38m investment in Terapin Studios, a US-based media platform controlled by Korea’s NPX Capital focused on bringing Korean digital comics to global markets.

  • North Asia
  • 02 August 2022
solar-panel-cleantech-01
Skip Capital, Stonepeak pursue Australia's Genex Power

Australia-listed renewable energy producer Genex Power has rejected an initial AUD 320m (USD 225m) buyout offer from Skip Capital and Stonepeak Partners, but it is open to further advances.

  • Australasia
  • 02 August 2022
yinglan-tan-insignia
Insignia raises $516m for latest Southeast Asia vintage

Insignia Venture Partners has raised USD 516m for its third Southeast Asia fund, comprising USD 388m for a core venture vehicle, an accompanying entrepreneurs’ pool of USD 28m, and a USD 100m annex fund.

  • Southeast Asia
  • 02 August 2022
textile-cloth-clothing-01
Centurium leads $200m round for China textile tech specialist

Centurium Capital has led a USD 200m investment in NTX, a Shanghai-based textile technology start-up that aims to serve as an eco-friendly supply chain partner to fashion and apparel brands.

  • Greater China
  • 01 August 2022
avcj-southeast-asia-2022-lp
LPs worried by rising fund sizes in Southeast Asia - AVCJ Forum

LPs are encouraged by Southeast Asia’s fast-developing private equity ecosystem, but they are concerned that increases in fund sizes are outstripping that of the addressable market, the AVCJ Southeast Asia Forum heard.

  • Southeast Asia
  • 01 August 2022
yes-bank-building
Carlyle, Advent commit $1.1b to India's Yes Bank

The Carlyle Group and Advent International have together invested USD 1.1bn in India’s Yes Bank, acquiring equity shares and warrants that could enable them to own up to 20% of the lender.

  • South Asia
  • 01 August 2022
da-mi-xiao-mi
ABC Impact backs China autism therapy business

ABC Impact, a Singapore-based impact investor established by Temasek Trust, the philanthropic arm of Temasek Holdings, has led a USD 42m Series D for Da Mi & Xiao Mi (DMXM), a Chinese rehabilitation platform for children with autism spectrum disorder...

  • Southeast Asia
  • 01 August 2022
orthopedic-orthopaedics
Sylvan buys Singapore orthopaedics business

Singapore-based private equity firm Sylvan Group has taken a controlling position in Singapore Orthopaedic Specialists (SOS) as a bolt-on of recently acquired Artemis Health Ventures.

  • Southeast Asia
  • 31 July 2022
GIC looks to PE to drive returns amid rising inflation

Singapore’s GIC is increasing its private equity allocation as part of a broader alternatives-oriented effort to ensure that returns keep pace with elevated inflation.

  • Southeast Asia
  • 29 July 2022
mining-miner
Potentia agrees $623m exit from Australia's Micromine

Australia’s Potentia Capital has agreed to exit its position in local mining software provider Micromine to UK-based industrial software player AspenTech in a deal worth AUD 900m (USD 623m).

  • Australasia
  • 29 July 2022
enterprise-software-saas
B Capital, Kunlun back China process mining start-up

B Capital Group and Kunlun Capital have led a CNY 135 (USD 20m) Series A extension for China’s Prothentic Technology, a process mining specialist also known as Wangfanxin.

  • Greater China
  • 29 July 2022
asg-eye-hospital
India's ASG Eye Hospitals gets $188m from Kedaara, GA

Indian optometry chain ASG Eye Hospital has raised a INR 15bn (USD 188m) round led by Kedaara Capital and General Atlantic, setting up an exit for Investcorp.

  • South Asia
  • 29 July 2022
70 71 72
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013